Index tracked: Euro Equity Defensive Put Write index Total Return
TER
0.21%+ trans. 0.00%
Fund size
174 m EUR
Tracking difference
−0.08%3-year avg
🇮🇹 tax rate
—white list not published
Replication
Synthetic (swap)
Income
Accumulating
Launch 8 Jul 2020 · costs from the KID as of 2 Sept 2026 · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 5 Aug 2026
The objective of the Fund is capital appreciation. The Fund tracks the daily performance of an equity index, called the Euro Equity Defensive Put Write index (the 'Index'), less fees and costs and consequently is passively managed. The Fund invests in financial derivative instruments ('FDIs') with UBS AG, London Branch ('UBS') as counterparty. The Fund may also invest in securities (e.g. company shares and bonds issued by companies and governments). Under the terms of the FDIs, the performance of the Index is swapped from UBS to the Fund, and in return…
Performance since series start (in euro) — base 100
8 Jul 2020 → 8 Sept 2026 · dividends reinvested where declared by the issuer
High 162 (8 Sept 2026) · low 100 (29 Oct 2020) · last 162. Past performance is not indicative of future results.
The live sheet, always up to date rebalix.com/en/etf/IE00BLDGHT92 Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.